Sleep-disordered breathing in the elderly Source: Eur Respir Mon; 2009: 43: 179–204 Year: 2009
Association of vascular endothelial dysfunction with disease severity in obstructive sleep apnoea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation Source: Eur Respir J 2009; 33: 1195-1205 Year: 2009
Association between lipid peroxidation and inflammation in obstructive sleep apnoea Source: Eur Respir J 2006; 28: 378-385 Year: 2006
Independent associations between arterial bicarbonate, apnea severity and hypertension in a sleep apnea cohort Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea Source: Eur Respir J 2009; 34: 1390-1398 Year: 2009
Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea Source: International Congress 2019 – State of the art session: Sleep and breathing disorders Year: 2019
8-isoprostanes and resistin as markers of vascular damage in non-hypersomnolent obstructive sleep apnea patients Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Control of breathing Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-36-7, page=44 Year: 2005
Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease Source: Eur Respir J 2013; 41: 616-620 Year: 2013
Is obstructive sleep apnoea a risk factor for cardiovascular disease? Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy Year: 2005
Obstructive sleep apnoea and COPD Source: Eur Respir Mon 2013; 59: 135-143 Year: 2013
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities Source: Eur Respir J 2007; 29: 156-178 Year: 2007
Obstructive sleep apnoea: who should be treated? Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives Year: 2005
Early changes in blood pressure, vascular and heart function in obstructive sleep apnoea (OSA). Impact of treatment Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Subclinical atherosclerosis in obstructive sleep apnea (OSA): The EPIOSA study Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine Year: 2015
Pathophysiology of central sleep apnea Source: Annual Congress 2005 - Central sleep apnoea Year: 2005
Relationship of oxidative stress and endothelial dysfunction in sleep apnoea Source: Eur Respir J 2011; 37: 873-879 Year: 2011
The association between hypertension and neutrophil to lymphocyte ratio in patients with obstructive sleep apnea syndrome Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Treatment of obstructive and central sleep apnoea in heart failure: practical options Source: Eur Respir Rev 2007; 16: 183-188 Year: 2007